Liposomal formulations of synthetic MUC1 peptides: Effects of encapsulation versus surface display of peptides on immune responses

Bioconjugate Chemistry

Volumn 9, Issue 4, 1998, Pages 451-458

  Guan, Holly H ^a   Budzynski, Wladyslaw ^b   Koganty, R Rao ^b   Krantz, Mark J ^b   Reddish, Mark A ^b   Rogers, James A ^a   Longenecker, B Michael ^b   Samuel, John ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Biomira Inc   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; CYTOLOGY; EPITOPES; IMMUNE SYSTEM; PEPTIDES; T-CELLS; VACCINES;

CANCER VACCINE; CYTOKINES; EFFECT OF ENCAPSULATION; HUMORAL IMMUNE RESPONSE; IMMUNE RESPONSE; LIPOPEPTIDES; LIPOSOMAL FORMULATION; NONCONJUGATED; PROLIFERATIVE RESPONSE; SURFACE DISPLAYS;

LIPOSOMES;

EID: 0032127618     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970183n     Document Type: Article

References (54)

1. Gendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., and Burchell, J. (1988) A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. J. Biol Chem. 263, 12820-12823.
2. Zotter, S., Hageman, P. C., Lossnitzer, A., Mooi, W. J., and Hiljers, J. (1988) Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 11, 55-58.
3. Burchell, J., Gendler, S., Taylor-Papadimitriou, J., Girling, A., Lewis, A., Millis, R., and Lamport, D. (1987) Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Cancer Res. 47, 5476-5482.
4. Hull, S. R., Bright, A., Carraway, K. L., Abe, M., Hayes, D. F., and Kufe, D. W. (1989) Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line. Cancer Commun. 1, 261-267.
5. Finn, O. J. (1992) Antigen-specific, MHC-unrestricted T cells. Biotherapy 4, 239-249.
6. Jerome, K. R., Domenech, N., and Finn, O. J. (1993) Tumor-specific cytotoxic T cell clones from patients with breast and pancreatic adenocarcinoma recognize EBV-immortalized B cells transfected with polymorphic epithelial mucin complementary DNA. J. Immunol. 151, 1654-1662.
7. Longenecker, B. M., and MacLean, G. D. (1993) Prospects for mucin epitopes in cancer vaccines. Immunologist 1, 89-93.
8. Samuel, J., and Longenecker, B. M. (1995) Development of Active Specific Immunotherapeutic Agents Based on Cancer-associated Mucins. In Vaccine design-the subunit and adjuvant approach (M. F. Powell and M. J. Newman, Eds.) pp 875-890, Plenum Press, New York.
9. Finn, O. J., Jerome, K. R., Henderson, R. A., Pecher, G., Domenech, N., Magarian-Blander, J., and Barratt-Boyes, S. M. (1995) MUC-1 epithelial tumor mucin-based immunity and cancer vaccines. Immunol. Rev. 145, 61-89.
10. Agrawal, B., Reddish, M. A., Krantz, M. J., and Longenecker, B. M. (1995) Does pregnancy immunize against breast cancer? Cancer Res. 55, 2257-2261.
11. Agrawal, B., Reddish, M. A., and Longenecker, B. M. (1996) In vitro induction of MUC-1 peptide-specific type 1 T lymphocyte and cytotoxic T lymphocyte responses from healthy multiparous donors. J. Immunol. 157, 2089-2095.
12. Jerome, K. R., Kirk, A. D., Pecher, G., Ferguson, W. W., and Finn, O. J. (1997) A survivor of breast cancer with immunity to MUC-1 mucin, and lactational mastitis. Cancer Immunol. Immunother. 43, 355-360.
13. Ding, L., Lalani, E. N., Reddish, M., Koganty, R., Wong, T., Samuel, J., Yacyshyn, M. B., Meikle, A., Fung, P. Y. S., Taylor-Papadimitriou, J., and Longenecker, B. M. (1993) Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of murine mammary adenocarcinoma cells transfected with the human MUC1 gene Cancer Immunol. Immunother. 36, 9-17.
14. Allison, A. G., and Gregoriadis, G. (1974) Liposomes as immunological adjuvants. Nature 252, 252.
15. Alving, C. R. (1991) Liposomes as carriers of antigens and adjuvants. J. Immunol. Methods 140, 1-13.
16. Gregoriadis, G. (1990) Immunological adjuvants: a role for liposomes. Immunol. Today 11, 89-97.
17. Aramaki, Y., Fujii, Y., Yachi, K., Kikuchi, H., and Tsuchiya, S. (1994) Activation of systemic and mucosal immune response following nasal administration of liposomes. Vaccine 12, 1241-1245.
18. Glenn, G. M., Rao, M., Richards, R. L., Matyas, G. R., and Alving, C. R. (1995) Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A. Immunol. Lett. 47, 73-78.
19. Naito, S., Horino, A., Nakayama, M., Nakano, Y., Nagai, T., Mizuguchi, J., Komuro, K., and Uchida, T. (1996) Ovalbumin-liposome conjugate induces IgG but not IgE antibody production. Int. Arch. Allergy Immunol. 109, 223-228.
20. Therien, H. M., Lair, D., and Shahum, E. (1990) Liposomal vaccine: influence of antigen association on the kinetics of the humoral response. Vaccine 8, 558-562.
21. Samuel, J., Budzynski, W. A., Reddish, M., Ding, L., Zimmermann, G., Krantz, M., Koganty, R. R., and Longenecker, B. M. (1998) Immunogenicity and antitumor activity of a liposomal MUC1 peptide based vaccine. Int. J. Cancer 75, 295-302.
22. Merrifield, R. B. (1963) Solid-phase protein synthesis: I. The synthesis of a tetrapeptide. J. Am. Chem. Soc. 85, 2149-2154.
23. Ohsawa, T., Miura, H., and Harada, K. (1985) Improvement of encapsulation efficiency of water-soluble drugs in liposomes formed by the freeze-thawing method. Chem. Pharm. Bull. 33, 3945-3952.
24. Mayer, L. D., Hope, M. J., Cullis, P. R., and Janoff, A. S. (1985) Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim. Biophys. Acta 817, 193-196.
25. Hathcock, K. S. (1991) T cell enrichment by non-adherence to nylon. In Current Protocols in Immunology (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds.) p 3.2.1, Green Publishing and Wiley-Interscience, New York.
26. Schreiber, R. D. (1991) Measurement of mouse and human interferon-gamma. In Current Protocols in Immunology (J. E. Coligan, A. M. Kruisbeek, D. H. Margulies, E. M. Shevach, and W. Strober, Eds.) p 6.8.1, Green Publishing and Wiley-Interscience, New York.
27. Chtelain, R., Varkila, K., and Coffman, R. L. ( 1992) IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148, 1182-1187.
28. Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., and Coffman, R. L. (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
29. Van Rooijen, N., and Van Nieuwmegen, R. (1983) Association of an albumin antigen with phosphatidylcholine liposomes alters the nature of immunoglobulins produced during the immune response against the antigen. Biochim. Biophys. Acta 755, 434-438.
30. de Haan, A., Groen, G., Prop, J., van Rooijen, N., and Wilschut, J. (1996) Mucosal immunoadjuvant activity of liposomes: role of alveolar macrophages. Immunology 89, 488-493.
31. Shahum, E., and Therien, H. M. (1995) Liposomal adjuvanticity: effect of encapsulation and surface-linkage on antibody production and proliferative response. Int. J. Immunopharmacol. 17, 9-20.
32. Germain, R. N. (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76, 287-299.
33. Alving, C. R. (1995) Liposomal vaccines: clinical status and immunological presentation for humoral and cellular immunity. Ann. N.Y. Acad. Sci. 754, 143-152.
34. Roof, R. W., Luescher, I. F., and Unanue, E. R. (1990) Phospholipids enhance the binding of peptides to class II major histocompatibility molecules. Proc. Natl. Acad. Sci. U.S.A. 87, 1735-1739.
35. White, W. I., Cassatt, D. R., Madsen, J., Burke, S. J., Woods, R. M., Wassef, N. M., Alving, C. R., and Koenig, S. (1995) Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen. Vaccine 13, 1111-1122.
36. Zhou, F., Rouse, B. T., and Huang, L. (1992) Induction of cytotoxic T lymphocytes in vivo with protein antigen entrapped in membranous vehicles. J. Immunol. 149, 1599-1604.
37. Shahum, E., and Therien, H. M. (1994) Correlation between in vitro and in vivo behaviour of liposomal antigens. Vaccine 12, 1125-1131.
38. Scheicher, C., Mehlig, M., Dienes, H. P., and Reske, K. (1995) Uptake of microparticle-adsorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of interleukin-1 alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur. J. Immunol. 25, 1566-1572.
39. Ulrich, J. T., and Myers, K. R. (1995) Monophosphoryl Lipid A as an Adjuvant: past experiences and new directions. In Vaccine design-the subunit and adjuvant approach (M. F. Powell, and M. J. Newman, Eds.) p 516, Plenum Press, New York and London.
40. Kurosaki, T. (1997) Molecular mechanisms in B cell antigen receptor signaling. Curr. Opin. Immunol. 9, 309-318.
41. Clark, E. A., and Ledbetter, J. A. (1994) How B and T cells talk to each other. Nature 367, 425-428.
42. Dal Monte, P. R., and Szoka, F. C., Jr. (1989) Antigen presentation by B cells and macrophages of cytochrome c and its antigenic fragment when conjugated to the surface of liposomes. Vaccine 7, 401-408.
43. Dal Monte, P., and Szoka, F. C., Jr. (1989) Effect of liposome encapsulation on antigen presentation in vitro. Comparison of presentation by peritoneal macrophages and B cell tumors. J. Immunol. 142, 1437-1443.
44. Bachmann, M. F., and Zinkernagel, R. M. (1997) Neutralizing antiviral B cell responses. Annu. Rev. Immunol. 15, 235-270.
45. Setoh, K., Murakami, M., Araki, N., Fujita, T., Yamamoto, A., and Muranishi, S. (1995) Improvement of transdermal delivery of tetragastrin by lipophilic modification with fatty acids. J. Pharm. Pharmacol. 47, 808-811.
46. Powell, M. F., Grey, H., Gaeta, F., Sette, A., and Colon, S. (1992) Peptide stability in drug development: a comparison of peptide reactivity in different biological media. J. Pharm. Sci. 81, 731-735.
47. Phillips, N. C., and Emili, A. (1992) Enhanced antibody response to liposome-associated protein antigens: preferential stimulation of IgG2a/b production. Vaccine 10, 151-158.
48. Phillips, N. C. (1992) Liposomes and macrophage functions. Res. Immunol. 143, 251-252.
49. Friede, M., Van Regenmortel, M. H., and Schuber, F. (1993) Lyophilized liposomes as shelf items for the preparation of immunogenic liposome-peptide conjugates. Anal. Biochem. 211, 117-122.
50. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kolsch, E., Podlaski, F. J., Gately, M. K., and Rude, E. (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25, 823-829.
51. Guery, J. C., Galbiati, F., Smiroldo, S., and Adorini, L. (1996) Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice. J. Exp. Med. 183, 485-497.
52. Schmeer, N., Hoffmeister, E., Weiss, R., Hofer, R., and Baumgartner, W. (1997) Analysis of immunoglobulin classes and subclasses in response to infection of Balb/cJ and C57BL/6J mice with Coxiella burnetii. J. Vet. Med., Ser. B 44, 49-59.
53. Jouvin-Marche, E., Morgado, M. G., Leguern, C., Voegtle, D., Bonhomme, F., and Cazenave, P. A. (1989) The mouse Igh-1a and Igh-1b H chain constant regions are derived from two distinct isotypic genes. Immunogenetics 29, 92-97.
54. Martin, R. M., and Lew, A. M. (1998) Is IgG2a a good Th1 marker in mice? Immunol. Today 19, 49.